Hearing Teva in Talks to Buy Spectrum Pharma - Teva Pharmaceutical Indus (NYSE:TEVA)

According to a tweet from

, Financial Times Mergermarket is reporting that Teva (NASDAQ:

) is in talks to purchase Spectrum Pharma (NASDAQ:

This article may include mentions of rumors, chatter, or unconfirmed information. Readers should beware that while unconfirmed information may be correlated with increased volatility in securities, price movements based on unofficial information may change quickly based on increased speculation, clarification, or release of official news. Neither Benzinga nor its staff recommend that you buy, sell, or hold any security. We do not offer investment advice, personalized or otherwise. Benzinga recommends that you conduct your own due diligence and consult a certified financial professional for personalized advice about your financial situation.

TEVATeva Pharmaceutical Industries Ltd

$34.00-2.04%

Overview

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.